Genomic Analysis of Staphylococcus aureus of the Lineage CC130, Including mecC-Carrying MRSA and MSSA Isolates Recovered of Animal, Human, and Environmental Origins
Most methicillin resistant Staphylococcus aureus (MRSA) isolates harboring mecC gene belong to clonal advanced CC130. This lineage has historically been considered animal-associated because it lacks the human particular immune evasion cluster (IEC), and has been recovered from a broad vary of animal hosts. However, sporadic mecC-MRSA human infections have been reported, with proof of zoonotic transmission in some instances.
The target of this research was to research the whole-genome sequences of 18 S. aureus CC130 isolates [13 methicillin-resistant (mecC-MRSA) and five methicillin-susceptible (MSSA)] from totally different sequences sorts, obtained from a wide range of host species and origins (human, livestock, wild birds and mammals, and water), and from totally different geographic places, with a view to determine attribute markers and genomic options. Antibiotic resistance genes discovered amongst MRSA-CC130 had been these related to the SSCmecXI factor. Most MRSA-CC130 strains carried the same virulence gene profile. Moreover, six MRSA-CC130 possessed scn-sak and one MSSA-ST130 had lukMF’.
The MSSA-ST700 strains had been most divergent of their resistance and virulence genes. The pan-genome evaluation confirmed that 29 genes had been current solely in MRSA-CC130 (related to SCCmecXI) and 21 amongst MSSA-CC130 isolates (related to phages). The SCCmecXI, PBP3, GdpP, and AcrB had been an identical on the amino acid degree in all strains, however some variations had been present in PBP1, PBP2, PBP4, and YjbH proteins. An examination of the host markers confirmed that the three’ area of the bacteriophage φ3 was almost an identical to the reference sequence.
Truncated hlb gene was additionally present in scn-negative strains (two of them carrying sak-type gene). The dtlB gene of untamed rabbit isolates included novel mutations. The vwbp gene was discovered within the three MSSA-ST700 strains from small ruminants and in a single MSSA-ST130 from a crimson deer; these strains additionally carried a scn-type gene, totally different from the human and equine variants.
Lastly, a phylogenetic evaluation confirmed that the three MSSA-ST700 strains and the 2 MSSA-ST130 strains cluster individually from the remaining MRSA-CC130 strains with the etD2 gene as marker for the primary lineage. The presence of the human IEC cluster in some mecC-MRSA-CC130 strains means that these isolates might have had a human origin.
Prevalence and genomic investigation of Salmonella isolates recovered from animal food-chain in Xinjiang, China
Salmonella is a serious foodborne pathogen worldwide, inflicting severe instances of morbidity and mortality because of the consumption of contaminated meals. Animal-borne meals had been thought-about the primary supply of transferring Salmonella to people; nonetheless, route surveillance by genomic platforms alongside the food-chain is proscribed in China. Right here, we proceeded to the appliance of complete genome sequencing within the epidemiological evaluation of Salmonella remoted alongside the food-chain in Xinjiang, China. A complete of 2408 samples had been collected from farms, slaughterhouses, and markets, and subjected to the isolation of Salmonella strains. 314 (13.04%) of the samples had been optimistic for Salmonella.
Phenotypic antimicrobial resistance was carried out by the broth dilution technique utilizing 14 antimicrobial brokers belonging to 10 lessons for all 314 isolates. A number of consultant 103 isolates was subjected to whole-genome sequencing for understanding the Salmonella variety, together with serovars, antimicrobial and virulence genes, plasmid sorts, multi-locus sequence sorts, and allelic sorts. We discovered that S. Agona was the dominant serovar and O:4(B) was the dominant serogroup.
The dominant genotype was ST13 and every serovar has a singular MLST sample. Plasmids prediction reported Col(MGD2)_1 and Col(Ye4449)_1 because the dominant plasmids, along with the detection of IncFII(S)_1 and IncFIB(S)_1 carried by all S. Enteritidis isolates. Importantly, virulence genes prediction confirmed the presence of cdtB gene encoding typhoid toxins, spv genes, and pef gene cluster encoding fimbriae within the genomes of S. Indiana and S. Enteritidis. Phenotypic antimicrobial resistance recognized 92.04% of the sampled isolates as multi-drug resistance (MDR), with excessive resistance to tetracycline (78.03%; 245/314), amoxicillin/ clavulanic acid (75.80%; 238/314), and ampicillin (70.70%; 222/314).
Collectively, we firstly reported the prevalence of MDR Salmonella isolates harboring essential virulence elements transmission by way of animal-borne food-chain in Xinjiang, therefore route surveillance by whole-genome sequencing platform might facilitate recognition and venture early warning for the rising MDR clones alongside the food-chain.
Narrative evaluate of the novel coronavirus SARS-CoV-2: replace on genomic traits, transmissions and animal mannequin
Two outbreaks of extreme respiratory an infection brought on by extreme acute respiratory syndrome coronavirus (SARS-CoV) and the Center East respiratory syndrome coronavirus (MERS-CoV) brought about world pandemics and highlighted the significance of preparedness for respiratory CoVs. Lately, a 3rd extremely pathogenic CoV, extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first recognized in Wuhan, Hubei, China and posed a public well being disaster worldwide.
Recombinant Human CD44 antigen (CD44), partial |
|||
| CSB-EP004938HU1(F1)-1mg | Cusabio | 1mg | Ask for price |
|
Description: 28-380aa |
|||
Recombinant Human CD44 antigen (CD44), partial |
|||
| CSB-EP004938HU1(F1)-20ug | Cusabio | 20ug | Ask for price |
|
Description: 28-380aa |
|||
Recombinant Human CD44 antigen (CD44), partial |
|||
| CSB-EP004938HU2 | Cusabio | 10304 mg | Ask for price |
Recombinant Human CD44 antigen (CD44), partial |
|||
| CSB-EP004938HU2-100ug | Cusabio | 100ug | Ask for price |
|
Description: 21-649aa |
|||
Recombinant Human CD44 antigen (CD44), partial |
|||
| CSB-EP004938HU2-1mg | Cusabio | 1mg | Ask for price |
|
Description: 21-649aa |
|||
Recombinant Human CD44 antigen (CD44), partial |
|||
| CSB-EP004938HU2-20ug | Cusabio | 20ug | Ask for price |
|
Description: 21-649aa |
|||
Recombinant Human CD44 antigen(CD44),partial |
|||
| AP70137 | SAB | 1mg | EUR 1978 |
Recombinant Human CD44 antigen(CD44),partial |
|||
| AP77608 | SAB | 1mg | EUR 1978 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS7110829-002mgMammalianCell | MyBiosource | 0.02mg(Mammalian-Cell) | EUR 230 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS7110829-01mgMammalianCell | MyBiosource | 0.1mg(Mammalian-Cell) | EUR 370 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS7110829-5x01mgMammalianCell | MyBiosource | 5x0.1mg(Mammalian-Cell) | EUR 1470 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS7136923-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS7136923-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS7136923-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS7136923-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS967245-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS967245-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS967245-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human CD44 antigen (CD44), partial |
|||
| MBS967245-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
Recombinant Human CD44 antigen (CD44) ,partial |
|||
| RPC21057-100ug | Biomatik Corporation | 100ug | EUR 460.9 |
Recombinant Human CD44 antigen (CD44) ,partial |
|||
| RPC21057-1mg | Biomatik Corporation | 1mg | EUR 2237.8 |
Recombinant Human CD44 antigen (CD44) ,partial |
|||
| RPC21057-20ug | Biomatik Corporation | 20ug | EUR 258.7 |
Recombinant Human CD44 antigen (CD44), partial (Active) |
|||
| CSB-MP004938HU(F1) | Cusabio | 8764 mg | Ask for price |
Recombinant Human CD44 antigen (CD44), partial (Active) |
|||
| CSB-MP004938HU(F1)-100ug | Cusabio | 100ug | Ask for price |
|
Description: 21-220aa |
|||
Recombinant Human CD44 antigen (CD44), partial (Active) |
|||
| CSB-MP004938HU(F1)-1mg | Cusabio | 1mg | Ask for price |
|
Description: 21-220aa |
|||
Recombinant Human CD44 antigen (CD44), partial (Active) |
|||
| CSB-MP004938HU(F1)-20ug | Cusabio | 20ug | Ask for price |
|
Description: 21-220aa |
|||
Recombinant Human CD44 Antigen (CD44), Partial (Active) |
|||
| MBS7135684-002mg | MyBiosource | 0.02mg | EUR 230 |
Recombinant Human CD44 Antigen (CD44), Partial (Active) |
|||
| MBS7135684-01mg | MyBiosource | 0.1mg | EUR 370 |
Recombinant Human CD44 Antigen (CD44), Partial (Active) |
|||
| MBS7135684-5x01mg | MyBiosource | 5x0.1mg | EUR 1470 |
Recombinant Human CD44 antigen (CD44), partial (Active) |
|||
| MBS7136875-002mgMammalianCell | MyBiosource | 0.02mg(Mammalian-Cell) | EUR 230 |
Recombinant Human CD44 antigen (CD44), partial (Active) |
|||
| MBS7136875-01mgMammalianCell | MyBiosource | 0.1mg(Mammalian-Cell) | EUR 370 |
Recombinant Human CD44 antigen (CD44), partial (Active) |
|||
| MBS7136875-5x01mgMammalianCell | MyBiosource | 5x0.1mg(Mammalian-Cell) | EUR 1470 |
Recombinant Human CD44 antigen (CD44) ,partial (Active) |
|||
| RPC28031-100ug | Biomatik Corporation | 100ug | EUR 449.4 |
Recombinant Human CD44 antigen (CD44) ,partial (Active) |
|||
| RPC28031-20ug | Biomatik Corporation | 20ug | EUR 273.6 |
Recombinant Human CD44 antigen (CD44) (Δ507-536), partial |
|||
| CSB-EP004938HU(M)a2 | Cusabio | 10303 mg | Ask for price |
Recombinant Human CD44 antigen (CD44) (Δ507-536), partial |
|||
| CSB-EP004938HU(M)a2-100ug | Cusabio | 100ug | Ask for price |
|
Description: 21-649aa(Δ507-536) |
|||
Recombinant Human CD44 antigen (CD44) (Δ507-536), partial |
|||
| CSB-EP004938HU(M)a2-1mg | Cusabio | 1mg | Ask for price |
|
Description: 21-649aa(Δ507-536) |
|||
Recombinant Human CD44 antigen (CD44) (Δ507-536), partial |
|||
| CSB-EP004938HU(M)a2-20ug | Cusabio | 20ug | Ask for price |
|
Description: 21-649aa(Δ507-536) |
|||
Recombinant Human CD44 antigen |
|||
| MBS9420088-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant Human CD44 antigen |
|||
| MBS9420088-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Human CD44 antigen |
|||
| MBS9420088-1mg | MyBiosource | 1mg | EUR 1785 |
Recombinant Human CD44 antigen |
|||
| MBS9420088-5x1mg | MyBiosource | 5x1mg | EUR 7885 |
Recombinant Human CD44 antigen (CD44), partial, Biotinylated (Active) |
|||
| CSB-MP004938HU(F1)j1-B | Cusabio | 8806 mg | Ask for price |
Recombinant Human CD44 antigen (CD44), partial, Biotinylated (Active) |
|||
| CSB-MP004938HU(F1)j1-B-100ug | Cusabio | 100ug | Ask for price |
|
Description: 21-220aa |
|||
Recombinant Human CD44 antigen (CD44), partial, Biotinylated (Active) |
|||
| CSB-MP004938HU(F1)j1-B-1mg | Cusabio | 1mg | Ask for price |
|
Description: 21-220aa |
|||
Recombinant Human CD44 antigen (CD44), partial, Biotinylated (Active) |
|||
| CSB-MP004938HU(F1)j1-B-20ug | Cusabio | 20ug | Ask for price |
|
Description: 21-220aa |
|||
Recombinant Human CD44 antigen (CD44), partial, Biotinylated (Active) |
|||
| MBS9018397-002mgMammalianCell | MyBiosource | 0.02mg(Mammalian-Cell) | EUR 370 |
Recombinant Human CD44 antigen (CD44), partial, Biotinylated (Active) |
|||
| MBS9018397-01mgMammalianCell | MyBiosource | 0.1mg(Mammalian-Cell) | EUR 515 |
Recombinant Human CD44 antigen (CD44), partial, Biotinylated (Active) |
|||
| MBS9018397-5x01mgMammalianCell | MyBiosource | 5x0.1mg(Mammalian-Cell) | EUR 2175 |
Recombinant Human CD44 antigen (CD44) ,partial,Biotinylated (Active) |
|||
| RPC28068-100ug | Biomatik Corporation | 100ug | EUR 624.8 |
Recombinant Human CD44 antigen (CD44) ,partial,Biotinylated (Active) |
|||
| RPC28068-20ug | Biomatik Corporation | 20ug | EUR 425 |
Recombinant Mouse CD44 antigen (Cd44) |
|||
| MBS952992-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 2130 |
Recombinant Mouse CD44 antigen (Cd44) |
|||
| MBS952992-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | EUR 2765 |
Recombinant Mouse CD44 antigen (Cd44) |
|||
| MBS952992-01mgBaculovirus | MyBiosource | 0.1mg(Baculovirus) | EUR 2590 |
Recombinant Mouse CD44 antigen (Cd44) |
|||
| MBS952992-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 2250 |
Recombinant Mouse CD44 antigen (Cd44) |
|||
| MBS952992-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 2465 |
Recombinant Dog CD44 antigen (CD44), partial |
|||
| MBS1374162-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1130 |
Recombinant Dog CD44 antigen (CD44), partial |
|||
| MBS1374162-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | EUR 1385 |
Recombinant Dog CD44 antigen (CD44), partial |
|||
| MBS1374162-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1130 |
Recombinant Dog CD44 antigen (CD44), partial |
|||
| MBS1374162-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1385 |
Recombinant Dog CD44 antigen (CD44), partial |
|||
| MBS1374162-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1730 |
Recombinant Rat CD44 antigen (Cd44), partial |
|||
| MBS948621-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1175 |
Recombinant Rat CD44 antigen (Cd44), partial |
|||
| MBS948621-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 935 |
Recombinant Rat CD44 antigen (Cd44), partial |
|||
| MBS948621-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1210 |
Recombinant Rat CD44 antigen (Cd44), partial |
|||
| MBS948621-02mgYeast | MyBiosource | 0.2mg(Yeast) | EUR 1375 |
Recombinant Rat CD44 antigen (Cd44), partial |
|||
| MBS948621-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1330 |
Recombinant Mouse CD44 antigen (Cd44), partial |
|||
| MBS7111361-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Bovine CD44 antigen (CD44), partial |
|||
| MBS1405812-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1130 |
Recombinant Bovine CD44 antigen (CD44), partial |
|||
| MBS1405812-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | EUR 1385 |
Recombinant Bovine CD44 antigen (CD44), partial |
|||
| MBS1405812-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1130 |
Recombinant Bovine CD44 antigen (CD44), partial |
|||
| MBS1405812-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1385 |
Recombinant Bovine CD44 antigen (CD44), partial |
|||
| MBS1405812-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1735 |
Recombinant Papio hamadryas CD44 antigen (CD44) |
|||
| MBS1204509-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Cricetulus griseus CD44 antigen (CD44) |
|||
| MBS1112547-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Human CD44 antigen (CD44) |
|||
| 1-CSB-EP004938HU | Cusabio |
|
|
|
Description: Recombinant Human CD44 antigen(CD44),partial expressed in E.coli |
|||
Human CD44 antigen (CD44) |
|||
| 1-CSB-EP004938HU1 | Cusabio |
|
|
|
Description: Recombinant Human CD44 antigen(CD44),partial expressed in E.coli |
|||
Recombinant Rat CD44 antigen (CD44) (R578A), partial |
|||
| CSB-EP4291RA(M) | Cusabio | 11511 mg | Ask for price |
Recombinant Rat CD44 antigen (CD44) (R578A), partial |
|||
| CSB-EP4291RA(M)-100ug | Cusabio | 100ug | Ask for price |
|
Description: 22-687aa(R578A) |
|||
Recombinant Rat CD44 antigen (CD44) (R578A), partial |
|||
| CSB-EP4291RA(M)-1mg | Cusabio | 1mg | Ask for price |
|
Description: 22-687aa(R578A) |
|||
Recombinant Rat CD44 antigen (CD44) (R578A), partial |
|||
| CSB-EP4291RA(M)-20ug | Cusabio | 20ug | Ask for price |
|
Description: 22-687aa(R578A) |
|||
Recombinant Papio hamadryas CD44 antigen (CD44), partial |
|||
| MBS7054322-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Cricetulus griseus CD44 antigen (CD44), partial |
|||
| MBS7054321-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Mesocricetus auratus CD44 antigen (CD44), partial |
|||
| MBS1383844-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1215 |
Recombinant Mesocricetus auratus CD44 antigen (CD44), partial |
|||
| MBS1383844-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | EUR 1465 |
Recombinant Mesocricetus auratus CD44 antigen (CD44), partial |
|||
| MBS1383844-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1215 |
Recombinant Mesocricetus auratus CD44 antigen (CD44), partial |
|||
| MBS1383844-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1465 |
Recombinant Mesocricetus auratus CD44 antigen (CD44), partial |
|||
| MBS1383844-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1900 |
Human CD44 Antigen (CD44) Protein |
|||
| abx680442-50g | Abbexa | 50 µg | EUR 225 |
Human CD44 Antigen (CD44) Protein |
|||
| abx653779-100g | Abbexa | 100 µg | EUR 200 |
Recombinant Macaca fascicularis CD44 antigen (CD44), partial (Active) |
|||
| CSB-MP4290MOV | Cusabio | 9868 mg | Ask for price |
Recombinant Macaca fascicularis CD44 antigen (CD44), partial (Active) |
|||
| CSB-MP4290MOV-100ug | Cusabio | 100ug | Ask for price |
|
Description: 21-650aa |
|||
Recombinant Macaca fascicularis CD44 antigen (CD44), partial (Active) |
|||
| CSB-MP4290MOV-1mg | Cusabio | 1mg | Ask for price |
|
Description: 21-650aa |
|||
Recombinant Macaca fascicularis CD44 antigen (CD44), partial (Active) |
|||
| CSB-MP4290MOV-20ug | Cusabio | 20ug | Ask for price |
|
Description: 21-650aa |
|||
Human CD44 Antigen (CD44) CLIA Kit |
|||
| 20-abx491853 | Abbexa |
|
|
Human CD44 Antigen (CD44) ELISA Kit |
|||
| abx156677-100g | Abbexa | 100 µg | EUR 2950 |
Human CD44 Antigen (CD44) ELISA Kit |
|||
| abx156677-200g | Abbexa | 200 µg | EUR 5575 |
Human CD44 Antigen (CD44) ELISA Kit |
|||
| abx156677-50g | Abbexa | 50 µg | EUR 618.75 |
Human CD44 antigen, CD44 ELISA KIT |
|||
| ELI-02342h | Lifescience Market | 96 Tests | EUR 988.8 |
Human CD44 Antigen (CD44) Peptide (OVA) |
|||
| 20-abx651825 | Abbexa |
|
|
Human CD44 Antigen (CD44) Peptide (OVA) |
|||
| abx651825-5mg | Abbexa | 5 mg | EUR 550 |
Human CD44/ CD44 antigen ELISA Kit |
|||
| E0426Hu | Sunlong | 1 Kit | EUR 515 |
|
Description: LHR,MDU2,MDU3,MIC4,CDw44,Phagocytic glycoprotein I,Epican,Extracellular matrix receptor III,GP90 lymphocyte homing/adhesion receptor,HUTCH-I,Heparan sulfate proteoglycan,Hermes antigen,Hyaluronate receptor,Phagocytic glycoprotein 1,PGP-I,ECMR-III,PGP-1,CD44 |
|||
Human CD44(CD44 antigen) ELISA Kit |
|||
| EKF57197-48T | Biomatik Corporation | 48T | EUR 396.9 |
Human CD44(CD44 antigen) ELISA Kit |
|||
| EKF57197-5x96T | Biomatik Corporation | 5x96T | EUR 2693.25 |
Human CD44(CD44 antigen) ELISA Kit |
|||
| EKF57197-96T | Biomatik Corporation | 96T | EUR 567 |
Human CD44(CD44 antigen) ELISA Kit |
|||
| EH0654 | FN Test | 96T | EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
|||
Human CD44/CD44 antigen ELISA Kit |
|||
| E45K00467 | EnoGene | 96T | EUR 975 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx007560 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx011738-100g | Abbexa | 100 µg | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx011738-100ug | Abbexa | 100 ug | EUR 526.8 |
CD44 Antigen (CD44) Antibody |
|||
| abx011738-10g | Abbexa | 10 µg | EUR 350 |
CD44 Antigen (CD44) Antibody |
|||
| abx011738-200g | Abbexa | 200 µg | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx001198-100l | Abbexa | 100 µl | EUR 400 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx001198 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx001198-20l | Abbexa | 20 µl | EUR 175 |
CD44 Antigen (CD44) Antibody |
|||
| abx001198-50l | Abbexa | 50 µl | EUR 275 |
CD44 Antigen (CD44) Antibody |
|||
| abx015801-100ul | Abbexa | 100 ul | EUR 493.2 |
CD44 Antigen (CD44) Antibody |
|||
| abx015801-1mg | Abbexa | 1 mg | EUR 362.5 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx019050 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx019050-1mg | Abbexa | 1 mg | EUR 300 |
CD44 Antigen (CD44) Antibody |
|||
| abx021434-02mg | Abbexa | 0.2 mg | EUR 644.4 |
CD44 Antigen (CD44) Antibody |
|||
| abx021435-02mg | Abbexa | 0.2 mg | EUR 644.4 |
CD44 Antigen (CD44) Antibody |
|||
| abx025270-400l | Abbexa | 400 µl | EUR 525 |
CD44 Antigen (CD44) Antibody |
|||
| abx025270-400ul | Abbexa | 400 ul | EUR 627.6 |
CD44 Antigen (CD44) Antibody |
|||
| abx025270-80l | Abbexa | 80 µl | EUR 281.25 |
CD44 Antigen (CD44) Antibody |
|||
| abx111485-100l | Abbexa | 100 µl | EUR 612.5 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx111485 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx122068-100l | Abbexa | 100 µl | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx122068-100ug | Abbexa | 100 ug | EUR 469.2 |
CD44 Antigen (CD44) Antibody |
|||
| abx122068-20l | Abbexa | 20 µl | EUR 337.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx122068-50l | Abbexa | 50 µl | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx134411 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx130862-100l | Abbexa | 100 µl | EUR 250 |
CD44 Antigen (CD44) Antibody |
|||
| abx130862-500l | Abbexa | 500 µl | EUR 312.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx137093-01mg | Abbexa | 0.1 mg | EUR 487.5 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx137093 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx137102-01mg | Abbexa | 0.1 mg | EUR 487.5 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx137102 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| 20-abx137492 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx137492-50tests | Abbexa | 50 tests | EUR 225 |
CD44 Antigen (CD44) Antibody |
|||
| abx139276-01mg | Abbexa | 0.1 mg | EUR 444 |
CD44 Antigen (CD44) Antibody |
|||
| abx139276-100l | Abbexa | 100 µl | EUR 287.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx139276-500l | Abbexa | 500 µl | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx139277-01mg | Abbexa | 0.1 mg | EUR 444 |
CD44 Antigen (CD44) Antibody |
|||
| abx139277-100l | Abbexa | 100 µl | EUR 287.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx139277-500l | Abbexa | 500 µl | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx176874-1096tests | Abbexa | 10 × 96 tests | EUR 687.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx176874-596tests | Abbexa | 5 × 96 tests | EUR 325 |
CD44 Antigen (CD44) Antibody |
|||
| abx176874-96tests | Abbexa | 96 tests | EUR 262.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx176876-1096tests | Abbexa | 10 × 96 tests | EUR 725 |
CD44 Antigen (CD44) Antibody |
|||
| abx176876-596tests | Abbexa | 5 × 96 tests | EUR 337.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx176876-96tests | Abbexa | 96 tests | EUR 262.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx176877-1096tests | Abbexa | 10 × 96 tests | EUR 737.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx176877-596tests | Abbexa | 5 × 96 tests | EUR 337.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx176877-96tests | Abbexa | 96 tests | EUR 262.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx149089-100ug | Abbexa | 100 ug | EUR 526.8 |
CD44 Antigen (CD44) Antibody |
|||
| abx149089-1096tests | Abbexa | 10 × 96 tests | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx149089-596tests | Abbexa | 5 × 96 tests | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx149089-96tests | Abbexa | 96 tests | EUR 350 |
CD44 Antigen (CD44) Antibody |
|||
| abx341028-100l | Abbexa | 100 µl | EUR 400 |
CD44 Antigen (CD44) Antibody |
|||
| abx341028-50l | Abbexa | 50 µl | EUR 287.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx341087-100l | Abbexa | 100 µl | EUR 350 |
CD44 Antigen (CD44) Antibody |
|||
| abx341087-50l | Abbexa | 50 µl | EUR 250 |
CD44 Antigen (CD44) Antibody |
|||
| abx349872-96tests | Abbexa | 96 tests | EUR 287.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx172837-100l | Abbexa | 100 µl | EUR 712.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx172837-1ml | Abbexa | 1 ml | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx172837-200l | Abbexa | 200 µl | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx172838-100l | Abbexa | 100 µl | EUR 775 |
CD44 Antigen (CD44) Antibody |
|||
| abx172838-1ml | Abbexa | 1 ml | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx172838-200l | Abbexa | 200 µl | Ask for price |
CD44 Antigen (CD44) Antibody |
|||
| abx327913-100g | Abbexa | 100 µg | EUR 250 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx327913 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx327913-50g | Abbexa | 50 µg | EUR 187.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx332801-100ul | Abbexa | 100 ul | EUR 510 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx242943 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx242943-96tests | Abbexa | 96 tests | EUR 287.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx241364-100l | Abbexa | 100 µl | EUR 350 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx241364 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx241364-50l | Abbexa | 50 µl | EUR 250 |
CD44 Antigen (CD44) Antibody |
|||
| abx228869-100g | Abbexa | 100 µg | EUR 118.75 |
CD44 Antigen (CD44) Antibody |
|||
| abx228870-100g | Abbexa | 100 µg | EUR 62.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx229480-100g | Abbexa | 100 µg | EUR 118.75 |
CD44 Antigen (CD44) Antibody |
|||
| abx211318-100l | Abbexa | 100 µl | EUR 350 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx211318 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx211318-50l | Abbexa | 50 µl | EUR 250 |
CD44 Antigen (CD44) Antibody |
|||
| abx212503-100l | Abbexa | 100 µl | EUR 350 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx212503 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx212503-50l | Abbexa | 50 µl | EUR 250 |
CD44 Antigen (CD44) Antibody |
|||
| abx200293-100ug | Abbexa | 100 ug | EUR 393.6 |
CD44 Antigen (CD44) Antibody |
|||
| 20-abx200798 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
| abx231482-100g | Abbexa | 100 µg | EUR 350 |
CD44 Antigen (CD44) Antibody |
|||
| abx231482-100ug | Abbexa | 100 ug | EUR 610.8 |
CD44 Antigen (CD44) Antibody |
|||
| abx231483-100g | Abbexa | 100 µg | EUR 350 |
CD44 Antigen (CD44) Antibody |
|||
| abx231483-100ug | Abbexa | 100 ug | EUR 577.2 |
CD44 Antigen (CD44) Antibody |
|||
| abx402236-200g | Abbexa | 200 µg | EUR 287.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx432475-100g | Abbexa | 100 µg | EUR 387.5 |
CD44 Antigen (CD44) Antibody |
|||
| abx432475-200ul | Abbexa | 200 ul | EUR 460.8 |
Right here, we concentrate on the latest advances of the novel CoV, and talk about its genomic similarity with different CoVs, transmission, animal mannequin and scientific therapy of coronavirus illness 2019 (COVID-19) induced by SARS-CoV-2, which assist epidemic prevention and management, and information therapy methods.
